Letter from Publisher
Dear Readers,
Cardiovascular diseases (CVDS) appear to have turned into a silent epidemic in the country. Many may find it unbelievable but CVDS account for nearly 27 per cent of all deaths in India and it is, without a doubt, a figure that concerns all in the healthcare sector. It is a case of poor heart health, a major cause of growing mortality.
Although pharmacological treatments have been developed to reduce the progression of CVDS and even treat them, the best way, like any other disease, is to prevent it. Nutraceuticals seem to have great potential in maintaining human health, including heart health.
Our content team has tried to find out what role nutraceuticals play in promoting heart health. While taking the 360-degree view of nutraceuticals, its relevance in the prevention of CVDS has also been explored.
Food and beverages for wellness is one area where a lot of innovations are taking place and still more are required to bring in more customers. Our content team has covered interesting developments in the food industry on how companies are making efforts to innovate and launch novel products into the growth market.
In addition we have interesting interviews where the team has interacted with a Singapore-based food tech startup that aims to set up an eco-friendly production facility utilising its proprietary technology to produce up to six tonnes of vegetables and 1,400 tonnes of edible plant protein per annum by minimising carbon emission impact. The technology underpins what the firm calls the Hydroponics Integrating Microalgae and Solar Energy System (HIMASS), a process that incorporates artificial intelligence, solar panels and water upcycling technologies to produce its food items within a self-sustaining ecosystem.
In another piece, the team interacted with a Japanese company that is eyeing expansion in the Indian market through its ingredient, which seemingly has a lot of potential when it comes to healthy ageing and good for heart health.
Besides we have an informative article from an expert touching on how beneficial are essential phospholipids in Inflammatory Bowel Diseases (IBD)? In India IBD'S prevalence has grown substantially, rising from 0.1 per cent in 2006 to over 5 per cent in 2023. The study has also revealed that IBD now accounts for over 5 per cent of individuals experiencing lower gastrointestinal symptoms, including chronic abdominal pain, changes in bowel habits, and persistent diarrhoea. At present, there is no cure for IBD as such.
I am sure you will enjoy reading this informative edition.
Thanks & Regards,